Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rademikibart in Acute Asthma Exacerbation
NCT06940141Phase 2Completed
- Sponsor
- Connect Biopharma
- Start
- Aug 2025
- Primary completion
- Jul 2026
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of rademikibart in asthma, sponsored by Connect Biopharma. Started Aug 2025; status: completed.
02
Drugs
rademikibart
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06940141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06940141.